Dont Eat Me | List of Frontiers open access articles

Review

Published on 06 Jul 2023

New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway

in Pharmacology of Anti-Cancer Drugs

Han Deng
Guan Wang
Shengyan Zhao
Yiran Tao
Zhixiong Zhang
Jinliang Yang
Yi Lei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228962

11,960 views
30 citations

Original Research

Published on 18 Dec 2023

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells

in Vaccines and Molecular Therapeutics

Teresa R. Wagner
Simone Blaess
Inga B. Leske
Desiree I. Frecot
Marius Gramlich
Bjoern Traenkle
Philipp D. Kaiser
Dominik Seyfried
Sandra Maier
Amélie Rezza

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264179

6,627 views
12 citations

Original Research

Published on 20 Jul 2023

Cuproptosis-related gene expression is associated with immune infiltration and CD47/CD24 expression in glioblastoma, and a risk score based on these genes can predict the survival and prognosis of patients

in Neuro-Oncology and Neurosurgical Oncology

Erliang Li
Huanhuan Qiao
Jin Sun
Qiong Ma
Li Lin
Yixiang He
Shuang Li
Xinggang Mao
Xiaoping Zhang
Bo Liao

Frontiers in Oncology

doi 10.3389/fonc.2023.1011476

4,271 views
8 citations

Original Research

Published on 28 Jun 2022

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

in Cancer Immunity and Immunotherapy

Bin Zhang
Yongheng Shu
Shichuan Hu
Zhongbing Qi
Yanwei Chen
Jinhu Ma
Yunmeng Wang
Ping Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.897561

4,962 views
13 citations

Mini Review

Published on 19 Mar 2024

Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma

in Cancer Immunity and Immunotherapy

Patrick Nylund
Anna Nikkarinen
Sara Ek
Ingrid Glimelius

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373269

6,563 views
6 citations

Review

Published on 14 Nov 2023

The cross-talk between macrophages and tumor cells as a target for cancer treatment

in Cancer Metabolism

Muhammad Aizaz
Aakif Khan
Faisal Khan
Maria Khan
Ebraheem Abdu Musad Saleh
Maryum Nisar
Natalia Baran

Frontiers in Oncology

doi 10.3389/fonc.2023.1259034

9,520 views
18 citations

Original Research

Published on 24 Apr 2024

Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody

in Cancer Immunity and Immunotherapy

Anja Seckinger
Vanessa Buatois
Valéry Moine
Bruno Daubeuf
Françoise Richard
Laurence Chatel
Alizée Viandier
Nicolas Bosson
Emeline Rousset
Krzysztof Masternak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1378813

10,113 views
5 citations

Articles

New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells

Cuproptosis-related gene expression is associated with immune infiltration and CD47/CD24 expression in glioblastoma, and a risk score based on these genes can predict the survival and prognosis of patients

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity

Empowering macrophages: the cancer fighters within the tumour microenvironment in mantle cell lymphoma

The cross-talk between macrophages and tumor cells as a target for cancer treatment

Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody